Skip to content

About
News
Clinicians
Patients
Research

Menu

About
News
Clinicians
Patients
Research

AMD Publications

All
Retina
Cornea
AMD
CNV
RVO
DME
ROP
Keratoconus
Dry Eye
Glaucoma

Menu

All
Retina
Cornea
AMD
CNV
RVO
DME
ROP
Keratoconus
Dry Eye
Glaucoma

Re: Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group: Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials

Ophthalmology

March 2017

Seven-year Trends in Visual Acuity at First Presentation in Patients with Neovascular AMD

Ophthalmology

February 2017

Twelve-Month Outcomes of Ranibizumab vs. Aflibercept for Neovascular Age-Related Macular Degeneration: Data from an Observational Study

Ophthalmology

December 2016

Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration

British Journal of Ophthalmology

December 2016

Treatment Patterns and Visual Outcomes during the Maintenance Phase of Treat-and-Extend Therapy for Age-Related Macular Degeneration

Ophthalmology

November 2016

Long-Term Outcomes of Treatment of Neovascular Age-Related Macular Degeneration: Data from an Observational Study

Ophthalmology

September 2015

Two-year outcomes of “treat and extend” intravitreal therapy for neovascular age-related macular degeneration

Ophthalmology

June 2015

Time to initial clinician-reported inactivation of neovascular age-related macular degeneration treated primarily with ranibizumab

Ophthalmology

March 2015

Outcomes of persistently active neovascular age-related macular degeneration treated with VEGF inhibitors: observational study data

British Journal of Ophthalmology

March 2015

Consequences of long-term discontinuation of vascular endothelial growth factor inhibitor therapy in the patients with neovascular age-related macular degeneration

Acta Ophthalmologica

December 2014

Intravitreal therapy in bilateral neovascular age-related macular degeneration

Ophthalmology

October 2014

Reasons for discontinuation of intravitreal vascular endothelial growth factor inhibitors in neovascular age-related macular degeneration

Retina

September 2014

« Previous Page1 Page2 Page3 Page4 Page5 Page6 Next »

Email: ssi.ssr@sydney.edu.au
Phone: (+61) 421 787 808

Level 1, South Block
Sydney Eye Hospital
8 Macquarie Street
Sydney NSW 2000

Follow us

X-twitter Facebook Youtube

Quick links

Contact Us
Donate Now

Contact Us
Donate Now